NOVN.CH

105.24

+0.69%↑

LONN.CH

549.2

+1.37%↑

SDZ.CH

46.25

+1.89%↑

STMN.CH

88.36

+0.66%↑

BANB.CH

58.1

-0.85%↓

NOVN.CH

105.24

+0.69%↑

LONN.CH

549.2

+1.37%↑

SDZ.CH

46.25

+1.89%↑

STMN.CH

88.36

+0.66%↑

BANB.CH

58.1

-0.85%↓

NOVN.CH

105.24

+0.69%↑

LONN.CH

549.2

+1.37%↑

SDZ.CH

46.25

+1.89%↑

STMN.CH

88.36

+0.66%↑

BANB.CH

58.1

-0.85%↓

NOVN.CH

105.24

+0.69%↑

LONN.CH

549.2

+1.37%↑

SDZ.CH

46.25

+1.89%↑

STMN.CH

88.36

+0.66%↑

BANB.CH

58.1

-0.85%↓

NOVN.CH

105.24

+0.69%↑

LONN.CH

549.2

+1.37%↑

SDZ.CH

46.25

+1.89%↑

STMN.CH

88.36

+0.66%↑

BANB.CH

58.1

-0.85%↓

Search

Roche Holding AG

Avatud

SektorTervishoid

300.4 0.27

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

297.2

Max

303.2

Põhinäitajad

By Trading Economics

Sissetulek

1.7B

3.7B

Müük

-15B

16B

P/E

Sektori keskmine

22.865

35.739

Dividenditootlus

3.62

Kasumimarginaal

23.266

Töötajad

103,249

EBITDA

547M

6.5B

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.62%

3.08%

Turustatistika

By TradingEconomics

Turukapital

-368M

205B

Eelmine avamishind

300.13

Eelmine sulgemishind

300.4

Uudiste sentiment

By Acuity

50%

50%

149 / 371 Pingereas Healthcare

Roche Holding AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

1. okt 2025, 08:54 UTC

Suurimad hinnamuutused turgudel

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

18. sept 2025, 14:01 UTC

Omandamised, ülevõtmised, äriostud

Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion -- 2nd Update

18. sept 2025, 10:05 UTC

Suurimad hinnamuutused turgudel
Omandamised, ülevõtmised, äriostud

89bio Shares Soar Premarket on Takeover by Roche

18. sept 2025, 10:04 UTC

Omandamised, ülevõtmised, äriostud

Roche to Buy Maker of Fatty Liver Treatment 89bio for Up to $3.5 Billion -- Update

18. sept 2025, 05:37 UTC

Omandamised, ülevõtmised, äriostud

Roche to Buy 89bio for Up to $3.5 Billion

24. juuli 2025, 15:09 UTC

Tulu

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24. juuli 2025, 05:36 UTC

Tulu

Roche Backs 2025 Views After Strong Sales of Key Drugs

1. okt 2025, 20:33 UTC

Omandamised, ülevõtmised, äriostud

Roche Begins Tender Offer for 89bio Pursuant to Previously Announced Merger Agreement

1. okt 2025, 09:05 UTC

Kuumad aktsiad

Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental -- WSJ

18. sept 2025, 14:12 UTC

Omandamised, ülevõtmised, äriostud

89bio Stock Soars 86%. Why Roche Is Buying the Biopharma Company for $3.5 Billion. -- Barrons.com

18. sept 2025, 07:37 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Roche's 89bio Acquisition Gives Its Drug Pipeline Potential Blockbuster -- Market Talk

18. sept 2025, 05:09 UTC

Omandamised, ülevõtmised, äriostud

89bio Says Deal Reflects Potential of Pegozafermin Drug Candidate

18. sept 2025, 05:06 UTC

Omandamised, ülevõtmised, äriostud

Roche: Deal Is Expected to Close in 4Q

18. sept 2025, 05:06 UTC

Omandamised, ülevõtmised, äriostud

Roche: Deal Enhanc Portfolio in Cardiovascular, Renal, Metabolic Diseases

18. sept 2025, 05:05 UTC

Omandamised, ülevõtmised, äriostud

Roche: MASH Is One of Most Prevalent Comorbidities of Obesity

18. sept 2025, 05:05 UTC

Omandamised, ülevõtmised, äriostud

Roche: 89bio Developing Potential Treatment for Metabolic Dysfunction-Associated Steatohepatitis

18. sept 2025, 05:04 UTC

Omandamised, ülevõtmised, äriostud

Roche to Buy 89bio for $14.50 a Share in Cash, Contingent Value Right of Up to $6 a Share

18. sept 2025, 05:03 UTC

Omandamised, ülevõtmised, äriostud

Roche: Total Deal Value Is Up to $3.5B

18. sept 2025, 05:02 UTC

Omandamised, ülevõtmised, äriostud

Roche to Buy 89bio

18. sept 2025, 05:02 UTC

Omandamised, ülevõtmised, äriostud

Roche Enters Into Deal to Buy 89bio

8. aug 2025, 10:51 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

8. aug 2025, 07:39 UTC

Market Talk
Tulu

Roche Could Reach Peak Earnings Growth This Year -- Market Talk

5. aug 2025, 10:40 UTC

Market Talk

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24. juuli 2025, 06:52 UTC

Market Talk
Tulu

Roche Looks Confident in a Tricky Environment -- Market Talk

24. juuli 2025, 05:05 UTC

Tulu

Roche Backs 2025 View

24. juuli 2025, 05:05 UTC

Tulu

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24. juuli 2025, 05:04 UTC

Tulu

Correct: Roche 1H Sales Rose 4% On Year , Reported

24. juuli 2025, 05:04 UTC

Tulu

Roche 1H Net Pft Was Seen at CHF8.4B

24. juuli 2025, 05:04 UTC

Tulu

Roche 1H Net Pft CHF7.8B

24. juuli 2025, 05:03 UTC

Tulu

Roche 1H Oper Pft CHF12.0B

Võrdlus sarnastega

Hinnamuutus

Roche Holding AG Prognoos

Sentiment

By Acuity

149 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
help-icon Live chat